Biomagnetics Diagnostics Corp. Share Price

Stocks

BMGP

US09062Q1085

Advanced Medical Equipment & Technology

OTC Markets Traded
Real-time OTC Markets 02:10:11 22/11/2022 am IST 5-day change 1st Jan Change
0.000100 USD -.--% Intraday chart for Biomagnetics Diagnostics Corp. -.--% -

Valuation: Biomagnetics Diagnostics Corp.

Market Cap 32.27L 28.02L 26.12L 24L 45.39L 31Cr 45.89L 3.08Cr 1.2Cr 15Cr 1.21Cr 1.19Cr 51Cr P/E 2009
-6.29x
P/E 2010 -22.9x
Enterprise Value 33.64L 29.21L 27.24L 25.02L 47.32L 32Cr 47.84L 3.21Cr 1.26Cr 16Cr 1.26Cr 1.24Cr 53Cr EV / Sales 2009
-
EV / Sales 2010 -
Free-Float
100%
Yield 2009 *
-
Yield 2010 -
5 years 0
Extreme 0
0
10 years 0
Extreme 0
0.01
Manager TitleAgeSince
Chief Executive Officer - 26/02/1997
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 277
-1.05%-1.31%+21.93%+3.69% 21TCr
-0.38%-0.90%-0.11%-22.57% 14TCr
-2.51%+1.03%-24.38%+18.18% 13TCr
+0.67%+5.96%-54.30%-3.78% 7.02TCr
+0.24%+6.44%+11.21%+11.96% 5.11TCr
-0.28%+8.57%-15.66%-20.88% 5.01TCr
-0.63%-1.13%+20.99%+10.02% 3.95TCr
+5.28%+2.69%+38.04%+35.99% 3.68TCr
+0.57%+3.35%+102.61%+6.27% 2.99TCr
Average +0.18%+3.58%+11.15%+4.32% 7.61TCr
Weighted average by Cap. -0.49%+3.55%+3.52%+1.67%

Financials

2009 2010
Net sales - -
Net income -11.72L -10.18L -9L -9L -16.48L -11Cr -16.66L -1.12Cr -43.73L -5.57Cr -44.01L -43.04L -18Cr -2L -2L -2L -2L -3L -2.27Cr -3L -22.75L -9L -1.13Cr -9L -9L -3.75Cr
Net Debt 1L 1L 1L 93.79T 2L 1.2Cr 2L 12.04L 5L 59.97L 5L 5L 1.99Cr 1L 1L 1L 1L 2L 1.31Cr 2L 13.12L 5L 65.37L 5L 5L 2.17Cr
Logo Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s diagnostics system focuses on real-time testing for the actual presence of the virus or toxin or disease itself and not for antibodies produced by the body's immune system which may take anywhere from weeks to months to appear. The Company’s products include High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and Integrity Optical Biosensor (IOBS). Its HTS-MTP is designed to detect both qualitative chemical identification of the elements present in a substance and quantitative number of specific elements in a substance results from a single test. The Company triggered optical biosensor that is based on protein-receptor binding that brings two or more optically tagged receptors into close proximity using planar optical waveguides, thereby triggering fluorescence changes identified almost instantly by tiny on-board detectors.
Employees
2
  1. Stock Market
  2. Stocks
  3. BMGP Stock